Showing results (391-400 of 477) with videos related to
Sort By:
Pageof 48
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 10, 2020
Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stentsRidhima Goel, Davide Cao, Rishi Chandiramani, et al.American Heart Journal|November 8, 2020
Rationale and design of a randomized clinical trial comparing safety and efficacy of myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: The LANDMARK trialHideyuki Kawashima, Osama Soliman, Rutao Wang, et al.Journal of Thrombosis and Thrombolysis|March 12, 2021
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studiesToshiki Kuno, Bimmer Claessen, Davide Cao, et al.Circulation. Cardiovascular Interventions|December 9, 2015
Etiology, Frequency, and Clinical Outcomes of Myocardial Infarction After Successful Drug-Eluting Stent Implantation: Two-Year Follow-Up From the ADAPT-DES StudyTomotaka Dohi, Akiko Maehara, Bernhard Witzenbichler, et al.JACC. Cardiovascular Interventions|September 17, 2018
A Randomized Trial to Assess Regional Left Ventricular Function After Stent Implantation in Chronic Total Occlusion: The REVASC TrialKambis Mashayekhi, Thomas G Nührenberg, Aurel Toma, et al.International Journal of Cardiology|February 12, 2013
Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudySean van Diepen, L Kristin Newby, Renato D Lopes, et al.Circulation. Cardiovascular Interventions|October 26, 2018
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention PopulationSorin J Brener, Ajay J Kirtane, Michael J Rinaldi, et al.European Heart Journal|October 25, 2011
Antiplatelet agents for the treatment and prevention of atherothrombosisCarlo Patrono, Felicita Andreotti, Harald Arnesen, et al.Thrombosis and Haemostasis|November 27, 2015
Vascular risk levels affect the predictive value of platelet reactivity for the occurrence of MACE in patients on clopidogrel. Systematic review and meta-analysis of individual patient dataJean-Luc Reny, Pierre Fontana, Willibald Hochholzer, et al.JACC. Cardiovascular Interventions|January 31, 2021
Stent Thrombosis Risk Over Time on the Basis of Clinical Presentation and Platelet Reactivity: Analysis From ADAPT-DESKatherine H Chau, Ajay J Kirtane, Rachel M Easterwood, et al.Pageof 48